Published in J Pharm Pharmacol on February 01, 1975
The effects of D-pencillamine and levamisole on leucocyte chemotaxis in the rat. Br J Pharmacol (1978) 1.01
Penetration of naproxen and salicylate into inflammatory exudates in the rat. Ann Rheum Dis (1977) 0.88
A sponge implantation test in the rat as a model for screening anti-inflammatory activity [proceedings]. Br J Pharmacol (1976) 0.75
Effects of indomethacin on prostaglandin levels and leucocyte migration in an inflammatory exudate in vivo [proceedings]. Br J Pharmacol (1976) 0.75
Effects of D-penicillamine and levamisole on delayed hypersensitivity reactions in the rat and mouse [proceedings]. Br J Pharmacol (1978) 0.75
A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif. Nature (1990) 10.97
Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature (1980) 9.25
Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann Neurol (1999) 7.69
Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci U S A (2001) 6.68
A comparison of the Celera and Ensembl predicted gene sets reveals little overlap in novel genes. Cell (2001) 4.36
Nucleotide sequence of Abelson murine leukemia virus genome: structural similarity of its transforming gene product to other onc gene products with tyrosine-specific kinase activity. Proc Natl Acad Sci U S A (1983) 4.32
Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans. Nature (1996) 4.12
Regulation of bacterial cell division: temperature-sensitive mutants of Escherichia coli that are defective in septum formation. J Bacteriol (1975) 3.94
Microcircuitry of the direct and indirect pathways of the basal ganglia. Neuroscience (1998) 3.70
Characterization of the human cysteinyl leukotriene CysLT1 receptor. Nature (1999) 3.57
Full and partial posttraumatic stress disorder: findings from a community survey. Am J Psychiatry (1997) 3.55
The Memorial Delirium Assessment Scale. J Pain Symptom Manage (1997) 3.55
Nucleotide sequence analysis of the transforming region and large terminal redundancies of Moloney murine sarcoma virus. Proc Natl Acad Sci U S A (1980) 2.93
Stereological estimates of dopaminergic, GABAergic and glutamatergic neurons in the ventral tegmental area, substantia nigra and retrorubral field in the rat. Neuroscience (2008) 2.74
Obstruction due to retained carbon dioxide absorber canister wrapping. Anesth Analg (1996) 2.65
Conditional mutations involving septum formation in Escherichia coli. J Bacteriol (1967) 2.64
An association between actin and the major histocompatibility antigen H-2. Nature (1978) 2.63
Programmed ribosomal frameshifting generates the Escherichia coli DNA polymerase III gamma subunit from within the tau subunit reading frame. Nucleic Acids Res (1990) 2.61
High-dose beclomethasone inhaler in the treatment of asthma. Lancet (1983) 2.58
The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurones. Trends Neurosci (1990) 2.54
Evidence for a relationship between deoxyribonucleic acid metabolism and septum formation in Escherichia coli. J Bacteriol (1968) 2.54
Complete nucleotide sequence and organization of the Moloney murine sarcoma virus genome. Science (1981) 2.51
Studies on nucleic acid reassociation kinetics: reactivity of single-stranded tails in DNA-DNA renaturation. Proc Natl Acad Sci U S A (1975) 2.50
Bacterial cell division regulation: lysogenization of conditional cell division lon - mutants of Escherichia coli by bacteriophage. J Bacteriol (1973) 2.46
Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues. FEBS Lett (1993) 2.41
Bacterial cell division regulation: characterization of the dnaH locus of Escherichia coli. J Bacteriol (1974) 2.41
Effects of long term inhaled high dose beclomethasone dipropionate on adrenal function. Thorax (1983) 2.35
Tau proteins with FTDP-17 mutations have a reduced ability to promote microtubule assembly. FEBS Lett (1998) 2.26
The role of arachidonic acid oxygenation products in pain and inflammation. Annu Rev Immunol (1984) 2.25
A safety screening questionnaire for transcranial magnetic stimulation. Clin Neurophysiol (2001) 2.20
Identification and isolation of a membrane protein necessary for leukotriene production. Nature (1990) 2.20
MK886, a potent and specific leukotriene biosynthesis inhibitor blocks and reverses the membrane association of 5-lipoxygenase in ionophore-challenged leukocytes. J Biol Chem (1990) 2.14
Leukotriene B: a potential mediator of inflammation. J Pharm Pharmacol (1980) 2.13
The E. coli dnaY gene encodes an arginine transfer RNA. Cell (1986) 2.11
Inoculum-dependent division lag of Bacillus cultures and its relation to an endogenous factor(s) ("schizokinen"). J Bacteriol (1966) 2.07
Inhibition of lipid synthesis in Escherichia coli cells by the antibiotic cerulenin. Antimicrob Agents Chemother (1973) 2.06
Predicting complicated Crohn's disease and surgery: phenotypes, genetics, serology and psychological characteristics of a population-based cohort. Aliment Pharmacol Ther (2013) 2.05
Persistent increase in the motivation to take heroin in rats with a history of drug escalation. Neuropsychopharmacology (2000) 2.04
Regulation of bacterial cell division: genetic and phenotypic analysis of temperature-sensitive, multinucleate, filament-forming mutants of Escherichia. J Bacteriol (1974) 1.92
Electron microscopic analysis of D1 and D2 dopamine receptor proteins in the dorsal striatum and their synaptic relationships with motor corticostriatal afferents. J Neurosci (1995) 1.91
L-663,536 (MK-886) (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2 - dimethylpropanoic acid), a novel, orally active leukotriene biosynthesis inhibitor. Can J Physiol Pharmacol (1989) 1.88
Dopamine regulates the impact of the cerebral cortex on the subthalamic nucleus-globus pallidus network. Neuroscience (2001) 1.86
Alterations in the SMARCB1 (INI1) tumor suppressor gene in familial schwannomatosis. Clin Genet (2008) 1.84
Isolation and characterization of dnaX and dnaY temperature-sensitive mutants of Escherichia coli. Genetics (1979) 1.83
The Yersinia enterocolitica motility master regulatory operon, flhDC, is required for flagellin production, swimming motility, and swarming motility. J Bacteriol (1999) 1.81
Association of HLA B8 with spontaneous resolution in sarcoidosis. Thorax (1981) 1.80
Coeliac disease and diffuse interstitial lung disease. Lancet (1971) 1.80
Structure of tau exon 10 splicing regulatory element RNA and destabilization by mutations of frontotemporal dementia and parkinsonism linked to chromosome 17. Proc Natl Acad Sci U S A (1999) 1.73
Selective innervation of neostriatal interneurons by a subclass of neuron in the globus pallidus of the rat. J Neurosci (1998) 1.72
Models for tertiary structures. Myoglobin and lysozyme. J Chem Educ (1970) 1.70
Nucleotide sequence of the Escherichia coli replication gene dnaZX. Nucleic Acids Res (1986) 1.69
Immunocytochemical localization of D1 and D2 dopamine receptors in the basal ganglia of the rat: light and electron microscopy. Neuroscience (1995) 1.68
Oral ciprofloxacin compared with conventional intravenous treatment for Pseudomonas aeruginosa infection in adults with cystic fibrosis. Lancet (1987) 1.66
Length heteroplasmy of sturgeon mitochondrial DNA: an illegitimate elongation model. Genetics (1990) 1.65
Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2. J Pharmacol Exp Ther (2001) 1.65
Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles. J Pharmacol Exp Ther (1999) 1.63
Childhood abuse, adult health, and health care utilization: results from a representative community sample. Am J Epidemiol (2007) 1.63
Characterization of cholinergic neurons in the rat neostriatum. A combination of choline acetyltransferase immunocytochemistry, Golgi-impregnation and electron microscopy. Neuroscience (1984) 1.60
Mycobacterial isolations in young adults with cystic fibrosis. Thorax (1984) 1.60
Urinary leukotriene E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects. Am Rev Respir Dis (1991) 1.59
Leukotriene B4: a mediator of vascular permeability. Br J Pharmacol (1981) 1.57
Gender differences in susceptibility to posttraumatic stress disorder. Behav Res Ther (2000) 1.57
Frameshift suppression at tandem AGA and AGG codons by cloned tRNA genes: assigning a codon to argU tRNA and T4 tRNA(Arg). Nucleic Acids Res (1990) 1.56
Social phobia in adults with stuttering. Am J Psychiatry (1996) 1.55
Setting diagnostic thresholds for social phobia: considerations from a community survey of social anxiety. Am J Psychiatry (1994) 1.54
Altered insulin secretory responses to glucose in subjects with a mutation in the MODY1 gene on chromosome 20. Diabetes (1995) 1.54
Work organization and ergonomics. Appl Ergon (2000) 1.53
Growth of phages lambda, phiX174, and Ml3 requires the dnaZ (previously dnaH) gene product of Escherichia coli. Biochem Biophys Res Commun (1974) 1.53
Relationship of activity in the subthalamic nucleus-globus pallidus network to cortical electroencephalogram. J Neurosci (2000) 1.52
Synaptic input and output of parvalbumin-immunoreactive neurons in the neostriatum of the rat. Neuroscience (1994) 1.52
Cell division of the Escherichia coli lon- mutant. Mol Gen Genet (1970) 1.51
Influence of moderate daily wine consumption on body weight regulation and metabolism in healthy free-living males. J Am Coll Nutr (1997) 1.51
Pharmacology of L-660,711 (MK-571): a novel potent and selective leukotriene D4 receptor antagonist. Can J Physiol Pharmacol (1989) 1.50
Pelvic lipomatosis: 35-year experience. J Urol (1988) 1.50
Surgical delay in the management of dog bite injuries in children, does it increase the risk of infection? J Plast Reconstr Aesthet Surg (2006) 1.50
Cloning of the Escherichia coli dnaZX region and identification of its products. Mol Gen Genet (1983) 1.49
Hospitalised patients' views on doctors and white coats. Med J Aust (2001) 1.48
Leukotriene B4: an inflammatory mediator in vivo. Prostaglandins (1981) 1.48
Anti-inflammatory drugs, prostaglandins and leucocyte migration. Agents Actions (1976) 1.45
A method for extracting ferruginous bodies from sputum and pulmonary tissue. Am J Clin Pathol (1972) 1.44
Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor. Br J Pharmacol (1997) 1.44
Physicochemical evolution and molecular adaptation of the cetacean and artiodactyl cytochrome b proteins. Mol Biol Evol (2004) 1.44
The relationship between wages and income and the timing and spacing of births: evidence from Swedish longitudinal data. Econometrica (1990) 1.43
The effects of salicylate on the activity of rat liver tryptophan pyrrolase in vitro and in vivo. Biochem J (1971) 1.43
Obesity-induced hypertension. Renal function and systemic hemodynamics. Hypertension (1993) 1.43
Physical trauma and breast cancer. Lancet (1994) 1.42
Input from the frontal cortex and the parafascicular nucleus to cholinergic interneurons in the dorsal striatum of the rat. Neuroscience (1992) 1.42
Characterization of the cryptic lambdoid prophage DLP12 of Escherichia coli and overlap of the DLP12 integrase gene with the tRNA gene argU. J Bacteriol (1989) 1.42
Pharmacology of montelukast sodium (Singulair), a potent and selective leukotriene D4 receptor antagonist. Can J Physiol Pharmacol (1995) 1.41
Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation. J Clin Invest (1995) 1.40
Changes in liver tryptophan and tryptophan pyrrolase activity after administration of salicylate and tryptophan to the rat. Biochem Pharmacol (1972) 1.40
Three incidents of industrial mass psychogenic illness: a preliminary report. J Occup Med (1978) 1.40
The myth of the Brooks method of embolization: a brief history of the endovascular treatment of carotid-cavernous sinus fistula. J Neurointerv Surg (2009) 1.39